Turn Therapeutics Inc.
TTRX | NASDAQ
$15.29
-$0.05 (-0.33%)
Sep 22, 2026, 4:00 PM ET · Market open
Company Profile
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
Key Executives
| Name | Position |
|---|---|
| Bradley E. Burnam | Founder, Chief Executive Officer & Director |
| Zuraiz Chaudhary | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer |
| Mohammed Zubair | Controller |
| Neilesh Shailesh Ghodadra | Chief Medical Officer & Director |
| Stephen Hahn FASTRO | Executive Clinical & Regulatory Lead |
Turn Therapeutics Inc.
| Country | United States |
| IPO Date | Oct 7, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Bradley E. Burnam |
Contact Details
250 N Westlake Blvd Westlake Village,
California 91362 United States
Stock Details
| Ticker Symbol | TTRX |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0002023016 |
| CUSIP Number | 90021W105 |
| ISIN Number | US90021W1053 |
| SIC Code | n/a |
Add to Watchlist
Select watchlists to add or remove TTRX